Psychotic Disorders - Schizophrenia Flashcards
Name 3 psychotic disorders you know.
Schizophrenia
Bipolar disorder
Major depressive disorder
What are the main symptoms of psychosis ?
Delusions, hallucinations and ‘lack of insight’
How are SCZ symptoms classified ?
Name which symptoms according to their class.
Positive (Type 1) : - auditory hallucinations - delusions - thought disorder - thought broadcasting. Negative (Type 2) : - lack of drive - social withdrawal - motor disturbance (catatonia). Cognition impaired
What is the prevalence of SCZ ?
When does it usually arise ?
What percentage of affected individuals attempt suicide ?
- 1% prevalence
- Onset: late teens / early 20s
- 40% attempt suicide
What are the possible causes of SCZ ?
- “It’s genetic” (17% dizygotic twins, 48% monozygotics)
- “It’s viral”
- Developmental disorder?
- The pink spot theory (rubish)
What are the main NTs involved in SCZ ?
DA - Amphetamine
5-HT - LSD
Glutamate - PCP
What are the “D1-like” DA Rs ?
What about the “D2-like DA Rs ?
D1-like = D1 + D5 D2-like = D2, D3, D4
What evidence led to the “Dopamine Hypothesis” of SCZ ?
• Amphetamine
Drugs release dopamine and produce symptoms identical to positive symptoms of
schizophrenia – blocked by antipsychotics
• D2-like DA R agonists
Drugs like apomorphine and bromocriptine (used in PD) produce positive symptoms of schizophrenia.
• Reserpine (antihypertensive drug that depletes DA from synaptic vesicles)
• D2-like DA R antagonists
Reduce positive symptoms of schizophrenia and amphetamine-induced behavioural changes.
Is there direct biochemical evidence supporting the DA hypothesis of SCZ ?
No, or at least it is not as supportive. There is only indirect evidence of this hypothesis.
Which DA pathways are affected in SCZ ?
How does this correlate w/ +ve and -ve symptoms.
The mesocortical pathway (VTA to PFC) in hypoactive (“hypofrontality”) –> -ve symptoms
The mesolimbic pathway (VTA to NAcc) is hyperactive –> +ve symptoms
In a normal individual, what is the interaction between the mesocortical and mesolimbic pathways ?
It is though that, normally, the mesocortical pathway inhibits thee mesolimbic pathway.
What do we mean by typical anti-psychotics ?
Anti-psychotics that cause “typical” side effects :
- postural hypotension
- sedation
- anti-muscarinic effects (dry mouth, blurred vision, contipation etc.)
Give examples of typical anti-psychotics.
Phenothiazines
- Chlorpromazine (aliphatic) –> low D2affinity (1, H1 and mAch receptor antagonist)
- Thioridazine (piperidine) (strong mAch receptor antagonist)
- Trifluoperazine/Fluphenazine* (piperazine) –> higher affinity (*depot administration - esters of decanoate/ethanate)
Thioxanthines
- Flupenthixol
Butyrophenones
- Haloperidol –> highest D2 affinity
Does a typical anti-psychotic binding affinity have any influence on its effect ?
Correlation of typical antipsycholtic binding affinity with clinical effect.
What effects do typical antipsychotics have on the different DA pathway ?
Which of these are desriable Vs non-desirable ?
Mesocorticolimbic tracts –> Neuroleptics prevent hallucinations ==> good
Nigrostriatal system –> Neuroleptics induce movement disorders (EPS) ==> bad
Tuberoinfundibular system (hypothalamic) –> Neuroleptics cause hyperprolactinaemia ==> bad